Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with mucopolysaccharidosis II (Hunter syndrome)

Overview of attention for article published in Orphanet Journal of Rare Diseases, April 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,521 followers.

Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with… https://t.co/JvtKFLZqGn

Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with mucop... http://t.co/FPmgKZjfFW

Immunogenicity of idursulfase, clinical outcomes in very young patients (16m-7.5y) with #HunterSyndrome http://t.co/RkWSVURsvk #mpsarticle

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.